Acetilsalicilatna kiselina Bausch Health 100 mg želučanootporne tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

acetilsalicilatna kiselina bausch health 100 mg želučanootporne tablete

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - acetilsalicilatna kiselina - želučanootporna tableta - urbroj: jedna želučanootporna tableta sadrži 100 mg acetilsalicilatne kiseline

Acetilsalicilatna kiselina Bausch Health 75 mg želučanootporne tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

acetilsalicilatna kiselina bausch health 75 mg želučanootporne tablete

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - acetilsalicilatna kiselina - želučanootporna tableta - urbroj: jedna želučanootporna tableta sadrži 75 mg acetilsalicilatne kiseline

Metaspon 1500 mg prašak za oralnu otopinu Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

metaspon 1500 mg prašak za oralnu otopinu

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - glukozaminsulfat natrijev klorid - prašak za oralnu otopinu - urbroj: jedna vrećica sadrži 1500 mg glukozaminsulfata (kao 1884 mg glukozaminsulfat natrijevog klorida što odgovara 1178 mg glukozamina i 384 mg natrijevog klorida).

Kerendia Europska Unija - hrvatski - EMA (European Medicines Agency)

kerendia

bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - sredstva koja djeluju na sustav renin-angiotenzina - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.

Livmarli Europska Unija - hrvatski - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Hyftor Europska Unija - hrvatski - EMA (European Medicines Agency)

hyftor

plusultra pharma gmbh - Сиролимус - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.